Elevated Risk of Multiple Sclerosis and Related Outcomes in Epstein-Barr Virus-Positive Infectious Mononucleosis: A Population-Based Cohort Study (P12-10.001)
To assess risk of multiple sclerosis (MS), demyelinating diseases, and other key outcomes in individuals diagnosed with Epstein-Barr Virus-positive infectious mononucleosis (EBV+ IM).
Authors
- Philip O. Buck (ORCID: https://orcid.org/0000-0002-3898-3669)
- Ali A. Duarte Garcia
- John Diaz‐Decaro (ORCID: https://orcid.org/0000-0001-6487-2113)
- Chun Fan
- Sigrid Payne DaVeiga
- Mark T. Keegan (ORCID: https://orcid.org/0000-0003-1427-6705)
- Susan A. Hall (ORCID: https://orcid.org/0000-0002-0015-0354)
- Robert M. Jacobson (ORCID: https://orcid.org/0000-0002-6355-8752)
- Jeffrey X. Yang (ORCID: https://orcid.org/0000-0002-6246-1967)
- Jennifer St. Sauver
- Cynthia S. Crowson (ORCID: https://orcid.org/0000-0001-5847-7475)
- Enejda Senko
Institutions
- WinnMed (US)
- Moderna Therapeutics (United States) (US)
Publication Details
- Journal
- Neurology
- Published
- 2025-04-07
- DOI
- https://doi.org/10.1212/wnl.0000000000212313
- Citations
- 1
- Primary Topic
- Viral-associated cancers and disorders
- Type
- article
- Field-Weighted Citation Impact
- 1.05